Adjuvant therapy following curative resection of metastases

Christina Wu, Tanios Bekaii-Saab

Research output: Contribution to journalArticlepeer-review


Metastatic colorectal cancer is the third most common cancer in the United States with 20 % of the patients presenting with metastatic disease on initial presentation. Sites of metastases are usually to the liver and lung, and less commonly to the peritoneum. Oligometastatic disease may be treated with the combination of systemic chemotherapy, locoregional chemotherapy and surgery to improve survival rates. Thus, the unique setting of adjuvant chemotherapy in metastatic colorectal cancer will be reviewed in this paper.

Original languageEnglish (US)
Pages (from-to)217-224
Number of pages8
JournalCurrent Colorectal Cancer Reports
Issue number3
StatePublished - Sep 1 2012


  • Adjuvant chemotherapy
  • Hepatic arterial infusion
  • Hepatic resection
  • Metastasectomy
  • Metastatic colorectal cancer
  • Pulmonary resection

ASJC Scopus subject areas

  • Hepatology
  • Oncology
  • Gastroenterology


Dive into the research topics of 'Adjuvant therapy following curative resection of metastases'. Together they form a unique fingerprint.

Cite this